Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (401-410 of 522) with videos related to

Pageof 53
Sort By:
Cancer Causes & Control : CCC|April 18, 2018
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
The Prostate|October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCHZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Frontiers in Oncology|July 5, 2016
Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer RiskJoy Shi, Kristan J Aronson, Anne Grundy, et al.
Prostate Cancer and Prostatic Diseases|October 9, 2013
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH databaseE H Allott, M R Abern, L Gerber, et al.
Cancer|November 15, 2018
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?Adriana C Vidal, Lauren E Howard, Amanda De Hoedt, et al.
The Prostate|September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Agricultural and Food Chemistry|August 29, 2007
Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate glandNavindra P Seeram, William J Aronson, Yanjun Zhang, et al.
Journal of Hepatology|April 3, 2019
Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in miceSem J Aronson, Robert S Bakker, Xiaoxia Shi, et al.
Cancer|January 3, 2025
Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancerPeris Castaneda, Paige K Kuhlmann, Jaruda Ithisuphalap, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2023
Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH CohortAndrei Sergeyev, Lin Gu, Amanda M De Hoedt, et al.
Pageof 53

Showing results (401-410 of 522) with videos related to

Sort By:
Pageof 53
Cancer Causes & Control : CCC|April 18, 2018
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
The Prostate|October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCHZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Frontiers in Oncology|July 5, 2016
Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer RiskJoy Shi, Kristan J Aronson, Anne Grundy, et al.
Prostate Cancer and Prostatic Diseases|October 9, 2013
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH databaseE H Allott, M R Abern, L Gerber, et al.
Cancer|November 15, 2018
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?Adriana C Vidal, Lauren E Howard, Amanda De Hoedt, et al.
The Prostate|September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Agricultural and Food Chemistry|August 29, 2007
Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate glandNavindra P Seeram, William J Aronson, Yanjun Zhang, et al.
Journal of Hepatology|April 3, 2019
Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in miceSem J Aronson, Robert S Bakker, Xiaoxia Shi, et al.
Cancer|January 3, 2025
Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancerPeris Castaneda, Paige K Kuhlmann, Jaruda Ithisuphalap, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2023
Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH CohortAndrei Sergeyev, Lin Gu, Amanda M De Hoedt, et al.
Pageof 53